Robotic Pancreatic Surgery | San Francisco Bay Area

Robotic Surgery in Pancreatic Cancer Care

Pancreatic surgery is among the most technically demanding areas of abdominal surgery, often requiring complex dissection near major vascular structures. Advances in robotic surgical platforms have expanded the possibilities of minimally invasive approaches for selected hepatopancreatobiliary (HPB) operations.

In carefully selected patients, robotic techniques may support precise dissection during complex pancreatic procedures performed for pancreatic cancer, including distal pancreatectomy and pancreaticoduodenectomy (Whipple procedure). These approaches are used only when strict oncologic principles can be maintained.

Dr. Geoffrey W. Krampitz is a fellowship-trained pancreatic cancer surgeon and hepatopancreatobiliary (HPB) surgical oncologist serving patients throughout the San Francisco Bay Area. His clinical practice focuses on complex pancreatic, liver, and gastrointestinal cancer surgery, incorporating advanced minimally invasive and robotic techniques when appropriate.

Robotic pancreatic surgery is not appropriate for every patient. Operative approach is determined by tumor biology, vascular involvement, prior therapy, and overall patient safety.

Advantages of Robotic Surgical Platforms

Robotic surgical systems provide several technical capabilities that may support complex minimally invasive procedures, including:

  • high-definition three-dimensional visualization

  • wristed instrument articulation allowing refined dissection

  • improved dexterity in confined anatomical spaces

  • enhanced precision during retroperitoneal and vascular dissection

These features can facilitate meticulous surgical technique during pancreatic operations when patient anatomy and oncologic considerations permit.

Robotic Surgery and Oncologic Principles

In pancreatic cancer surgery, operative technique must always be guided by oncologic principles rather than by the surgical platform itself. The primary objective of pancreatic resection remains complete tumor removal with negative margins and appropriate regional lymph node evaluation.

Minimally invasive approaches, including robotic surgery, are applied only when these oncologic standards can be maintained. Careful patient selection and detailed preoperative imaging are essential to determine whether a robotic approach is appropriate.

When minimally invasive surgery cannot safely achieve these objectives, open surgery remains the preferred approach.

Robotic Distal Pancreatectomy

Distal pancreatectomy removes the portion of the pancreas located in the body and tail.

For selected patients with tumors in this region, robotic distal pancreatectomy may allow the operation to be performed through smaller incisions while maintaining the same oncologic principles and lymph node evaluation as open surgery.

Potential benefits may include:

  • reduced postoperative discomfort

  • shorter hospital stay

  • faster return to normal activity

However, careful patient selection remains essential to ensure safe and effective oncologic resection.

Robotic Whipple Procedure

The robotic platform may also be used for pancreaticoduodenectomy (Whipple procedure) in carefully selected patients.

The Whipple procedure requires complex dissection around major vascular structures, including the superior mesenteric vein (SMV), portal vein, and superior mesenteric artery (SMA). Robotic systems may enhance visualization and dexterity in these anatomically demanding areas.

Not all patients are candidates for a minimally invasive Whipple procedure. Surgical approach is determined by tumor characteristics, vascular involvement, and overall patient condition.

The primary objective remains complete oncologic resection with appropriate lymph node evaluation.

Patient Selection and Oncologic Principles

The decision to perform robotic pancreatic surgery depends on several factors, including:

  • tumor location within the pancreas

  • relationship of the tumor to major vascular structures

  • prior abdominal surgery

  • response to systemic therapy

  • overall patient health

Technology is applied in service of oncologic principles rather than replacing them. When minimally invasive techniques are not appropriate, open surgery remains the safest and most effective option.

Programmatic Expertise in Robotic Surgery

Dr. Geoffrey W. Krampitz serves as Program Director of the Robotics Center of Excellence at Sutter Health Mills-Peninsula Medical Center, where he works with surgical leaders across multiple specialties to advance responsible adoption of robotic surgery and develop training initiatives for complex minimally invasive procedures.

Robotic pancreatic surgery is performed within a multidisciplinary cancer care framework that includes surgical oncology, medical oncology, gastroenterology, radiology, and pathology.

Consultation and Referral

For Patients

Individuals seeking evaluation for pancreatic cancer or other pancreatic tumors — including new diagnoses or second opinions — may Request a Consultation to discuss individualized treatment planning and whether minimally invasive surgery may be appropriate.

For Referring Physicians

Physicians wishing to refer a patient or discuss complex pancreatic cancer management may visit For Physicians for direct referral pathways and coordinated case review.